Press releases

2022-10-20

The Board of Directors of Eevia Health Plc ("Eevia" or the "Company") has today decided on a rights issue with preferential rights for Eevia's existing shareholders ("Rights Issue"). The target amount is approximately SEK 21.6 million. The proceeds shall primarily finance sales and marketing efforts and increase working capital. About 82 percent of the Rights Issue is covered by subscription and guarantee commitments.

2022-10-19
Regulatory

Following a successful quality audit by Eevia Health Plc's ("Eevia" or "The Company") French auditor Natural Ingredients, Eevia has received an 85 KEUR sales order for Bilberry extract from its distributor.

2022-10-19

Eevia Health Plc, ("Eevia" or "The Company"), has received a 20 KEUR sales order from a new Finnish customer.

2022-10-18

Eevia Health Plc, ("Eevia" or "The Company"), has received a 96 KEUR sales order from a European nutraceutical brand owner.

2022-10-12
Regulatory

Eevia Health Plc ("Eevia" or "The Company") is welcoming Dr. Tommi Kilpeläinen asits new Scientific Product Manager.

2022-10-11

The Extraordinary General Meeting of Shareholders of Eevia Health Plc, corp. reg. no 2825194-4 (the "Company") was held on October 11, 2022 in Seinäjoki, Finland, whereby the shareholders primarily resolved the following matters:

Authorizing the Board of Directors to decide on the issuance of shares, options, and other special rights

2022-09-22
Regulatory

Notice is given to the shareholders of Eevia Health Abp (Plc) to the Extraordinary General Meeting to be held on 11 October 2022 at 12:00 (Finnish time GMT +3) at the main office of Eevia Health Abp in Koulukatu 14, Seinäjoki, Finland.

The reception of persons who have registered for the meeting and the distribution of voting tickets will commence at 11:00.

2022-09-06

Eevia Health Plc, ("Eevia" or "The Company"), has received two small starting sales orders from South Korea and Taiwan, totaling approx. 24 KEUR for organically certified bilberry extracts.

2022-08-29
Regulatory

Eevia Health Plc ("Eevia" or "The Company") is releasing its quarterly financial report for the second quarter of 2022.

<<
1
...
3
4
5
6
...
10
>>